Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$SNPW ALERT>.028^ $25M REVS,Our 50-megawatt solar farm will provide over $25 million in revenue per year once operational, Our focus is to develop more projects in North and South America. With our new affiliates and partners providing a great platform for growth and success. $SNPW #SOLAR #renewableenergy Our 50-megawatt solar farm will provide over $25 million in revenue per year once operational, Our focus is to develop more projects in North and South America. With our new affiliates and partners providing a great platform for growth and success. $SNPW #SOLAR #renewableenergy
7:02 PM · May 11, 2021·Twitter Web App icymi
GROSSLY UNDERVALUED
NEWS/UPDATES JUST KEEP COMING
HEAVILY SHORTED
PPS FORECAST 1+ IN YEAR OR LESS
#DDAmanda Chart (CLASSIC Insider Play) on: $AVVH :
You can find these before they run:
What the Fact (Factor) Column is:
The Factor is a proprietary indicator used for scanning in #DDAmanda.
It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).
SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.
That's significant, and many times indicates that a run in the stock is coming.
New FBCD Filing today... Merging company already lined up... Looking great here... I bet we see a huge company merging like with $AVVH
https://www.otcmarkets.com/stock/FBCD/disclosure
SSM Monopoly Custodian Plays: $AVVH $FBCD $NSPT $AAPT $MDCE $GMZP $IFAN $MNVN $CBYI $CRGP
#shell #custodianship #custodian #RM #reversemergers #merger #lazar #moody #ssm #ssmmonopoly
$FTRK - next Moody R/M with 90 milly float
$MDCN TWEET! Will be pink current by end of week!
Dear Medican Enterprises Inc. (OTC:MDCN) Shareholders,
— Immediate Properties (@Immediateproper) May 24, 2021
Our attorney letter was posted over the weekend. We should be "Pink Current Information" with OTC Markets this week! $MDCN pic.twitter.com/oee5yCNxKG
$SNPW MEDRECYCLER>13 STATES NOW: More and more states coming onboard for Approving and Embracing the Pyrolysis Technology etc
https://www.americanchemistry.com/Media/PressReleasesTranscripts/ACC-news-releases/Arkansas-Is-13th-State-to-Pass-Advanced-Recycling-Legislation-to-Help-End-Plastic-Waste.html
GROSSLY UNDERVALUED
NEWS/UPDATES JUST KEEP COMING
$GVSI Custodianship Granted Yesterday
** MUST WATCH ** BABL $05 Synergy Custodian /Merger hearing for BABL (Buildablock Corp.) has been set for April 23, 2021. $1-$7 next weeks/months possible imho if BABL Merging in Crypto or MJ business. VYGVF Voyager digital tells the story how big Crypto business stocks can run. BABL excellent play for potential life changer IMHO. Looks like early birds insider boarding slowly start last days.
Ticker Buzz Cloud (24 hours)
Time Interval: 24hr | 12hr | 6hr | 3hr | 1hr
AABB AFPW AGYP AMC ANY APQT CACH CAN CBD CLSH DSCR EEENF ENZC FONU GDET GME GOLD GRSO GSFI GTCH HPIL IMO IMTL INCC INKW INND IPIX ISWH KBLB MINE NEXT NOW NSAV NWBO NWGC ONE OPTI PVDG PVSP RSI RUN SKDI SSET TGGI TPTW TSLA TTCM UAMM USEI VITX
GVSI--No one to contest, easy custodian grant. New George Sharp play...
https://twitter.com/dlarsmn/status/1384402253826564099?s=21
PSYCF is the BEST "shroom" Play available!
PSYCF is one of the first stocks to be included in the FIRST AND ONLY mushroom ETF.
PSYCF has put together an ALLSTAR TEAM.
Psyched wellness is really exciting they don't need any pharmaceutical approval for to bring their initial products to market!
ALL BULLISH
ALL-IN
.
The real garbage is QNTA... WOW HORRIBLE.
sure if you could get 10 million shares at .001 you could be dillutionally confident too.
Quit hyping garbage
Looks like insiders are very confident in WMHI future!$$$
Lol what is being sold today???
Just curious
WMHI...So Harry Zhang gave himself 100,000,000 shares at .001 when he came on board and this is where this new company is///
The company is looking for acquiring a viable operation.
That is a pathetic investment I will pass.
( WMHI ) = "SUPER-SHELL" Reverse Merger is in the cards SOON. imo oao!
Psyched Wellness Inc has JUUL, Compass Pathways, REDBULL, AURORA CANNABIS, Allstar Team.
These people are going to be wasting their time so PSYCF is worth a good look.
Keep in mind PSYCF is In the new publicly traded ETF.
Psyched Wellness will be the Big Winner of the psychedelic sector imo.
$OXIHF-.0075 cents Pioneer Green USA very undervalued at these prices IMO-
This company is a licensed Florida hemp grower with CBD Franchise stores ready to roll out in Canada/USA- CEO has almost 80 million shares as per filings- good motivation for sure...........
Agree. Early statues for sure.
This story has not even started yet.. I am hanging around for a major pharma buy-out.
Float 10,190,900...COVID 19 breakthrough...OTC PINK: (QNTA), announced today positive results in a safety and toxicity study conducted on its polarized drug candidate derived from a small molecular peptide found in scorpions, designed to treat patients with the SARS-CoV-2 virus, also known as COVID-19. The results showed no signs of toxicity in any of the patients involved in the study who were given the drug Escozine®, which is a polarized solution of the Rhopalurus princeps scorpion peptide owned by Medolife.
Medolife Rx Announces Positive Results in Clinical Safety Study on Its Polarized Drug Candidate for the Treatment of COVID-19
BURBANK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today positive results in a safety and toxicity study conducted on its polarized drug candidate derived from a small molecular peptide found in scorpions, designed to treat patients with the SARS-CoV-2 virus, also known as COVID-19. The results showed no signs of toxicity in any of the patients involved in the study who were given the drug Escozine®, which is a polarized solution of the Rhopalurus princeps scorpion peptide owned by Medolife.
The study, which was conducted in Santo Domingo of the Dominican Republic under the supervision of medical principal investigators, was conducted on over 500 patients, where data from one group of patients was used in the Company’s FDA pre-IND filing. Each patient was given Escozine® sublingually four times a day. During and after administration, a complete blood count (CBC) was conducted on each patient where the researchers measured various parameters to evaluate if the drug candidate was safe, such as hemoglobin (Hb), hematocrit (HCT), and red blood cells (RBCs) levels. There were no significant differences observed before or after administration. Additionally, there were no significant differences observed in white blood cells (WBCs), neutrophils, lymphocytes, monocytes, or eosinophils, concluding that the drug candidate was safe and non-toxic.
“A successful safety study is a pivotal step in the clinical development program for a new drug candidate and we could not be more enthusiastic about our results,” said Medolife CEO Dr. Arthur Mikaelian. “While our near-term goal is to work with the Ministry of Environment of The Dominican Republic to bring this drug to market, we are able to use this data in our programs around the world, including with our submissions to the United States Food and Drug Administration. While there is significant research that suggests the potential therapeutic benefits of extracted scorpion peptide, when paired with our proprietary polarization technology that increases efficacy and bioavailability in the body, we believe our product Escozine® could be a true breakthrough in the field of medicine with applications in a variety of focus areas and indications.”
The Company is currently involved in various clinical studies on Escozine® around the world. It is seeking product registration in the Dominican Republic for treatment of COVID-19 where this study took place, while simultaneously seeking approval in the United States, where it has filed data on Escozine® with the US Food and Drug Administration (FDA) as a Pre-Investigational New Drug (PIND #150335) as a COVID-19 therapeutic. Registration in the Dominican Republic would act as a proof-of-concept on the drug that would propel it forward in its path to market.
Medolife’s patented polarization technology increases the potency of single molecules and complex compounds. This technology is already used in various Medolife products, ranging from supplements to drug candidates.
++ BABL $028 +22% way $ land imho! Synergy Merger in works!! Merger Custodian updates in progress and can drop any day now.. This probably last bottom shares before start next massiv move. Looking forward $ land with this float if Crypto or MJ Merger drop next time...
https://www.synergymgtgroup.com/updates/update-31221
Ticker Buzz Cloud (24 hours)
Time Interval: 24hr | 12hr | 6hr | 3hr | 1hr
AABB AFPW AGYP AMC ANY APQT AVXL CBD CLSH CYDY DBMM DSCR EEENF ENZC FDFT FORW GME GNCP GSFI GTCH IMO IMTL INCC INND ISWH KBLB LTNC MINE NOW NSAV NWBO ONE OPTI PUMP PVDG PVSP RSI SIRC SKDI SNDL SSET TGGI TKAT TSLA TSNPD UAMM VBHI VITX WDLF XCRT
$AFFY .09 preparing for merger IMO. First change in OS since 2014 per OTC data. CEO Couchman is known for previous merger deals. Over $400 million in NOL’s. Could see multiple dollars per share since a big profitable company could have over $400 million in tax free income with a merger with AFFY.
Here is a article on it:
www.elementaryvalue.com/blog/affymax-affy-a-couchman-controlled-nol-stub
$MYRX .05 is another Couchman shell. It recently bought 1.4% of ENZN. It also has $147 million NOL’s.
Both of these stocks haven’t been noticed yet.
Float way too high
Float 3,573,164,755 07/30/2020
Authorized Shares 4,993,000,000
03/09/2021
Outstanding Shares 4,353,272,336
03/09/2021
the outstanding is almost up to the authorized, so reverse split or raise the authorized...
I don't see any upside with this share structure
Anyone in $EXMT? Lots of news coming
$IALS - final custodianship terminated in court today, 34 milly float, possible SPAC now
$CSOC..Volume and price breakout!
What are you talking about, a bankrupt dark company with 1.4 billion shares out..................... good god go get a job
PFWIQ, Great opportunity here! Low floater
$IALS - custodian termination court date on Tuesday, 34 milly float
https://twitter.com/mechanicaljdr/status/1367860153060499457?s=21
I feel WMHI will be my Best EVER shell!$$$
BOOOMMMMM!!!$$$$
.
MINE-looking to buy a cbd company-https://cbd-mfg.com/
Just grabbed 58s of ssof I waited patiently thanks for the heads up
MYRX is very thin. I think most of the float is locked up. .08 ask now.
Thanks, grabbed a few, she’s thin!
$MYRX .05 Couchman shell that hasn’t been noticed yet. Only 34 million OS and it recently bought 1.4% of ENZN after being in the dark since 2013!
https://seekingalpha.com/article/4235700-myrexis-overlooked-asset-deliver-big-payday-in-deal
$IALS - next Paul Moody R/M to go, his last one $KAVL is over $3 and has the same share structure as $IALS....
+++ BABL $021 Synergy Merger Custodianship!! Crypto or Marijuana R/M and BABL trade $0.5 $1 same week of R/M News for sure imho. Not surprising if BABL close a R/M next time and start into MJ or Crypto business. BABL will explode as soon as R / M News comes out. We will not be trading so extremely cheaply for a long time. Can also run as fast as NUGS a few years ago on his MJ R / M $00 up to $ 7 with this float.
Ticker Buzz Cloud (24 hours)
Time Interval: 24hr | 12hr | 6hr | 3hr | 1hr
AABB AGYP AMC ANY BIEL BRLL CAN CEO CLSH CYDY CZNI DBMM ENZC ERBB ESYL GNCP GSFI GTCH HCMC HPNN IDEX IGEN IMO INKW INND IQST LTNC MEDH MGON NOW NPHC NSAV ONE OPTI PVDG RSI RUN RXMD SANP SGTM SHMN SKDI SSET TPTW TSLA TSNP VITX WDLF ZAAG ZHUD
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |